ROSENWALD LINDSAY A MD 4

What Happened
Dr. Lindsay A. Rosenwald, MD — a reported 10% owner of Fortress Biotech, Inc. (FBIO) — was granted 475,424 restricted shares under the company's Long-Term Incentive Plan on March 18, 2026. The reported acquisition price is $0.00 (i.e., no cash paid); the filing lists the transaction as an award/grant (transaction code A).

Key Details

• Transaction date: 2026-03-18 (reported on Form 4 filed 2026-03-20).
• Transaction type/code: Award/Grant (A).
• Shares granted: 475,424 restricted shares.
• Reported price: $0.00 (no cash consideration).
• Footnote: Grant made pursuant to the Issuer's Long-Term Incentive Plan (see footnote F1).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Timeliness: Filed two days after the transaction date (appears timely under Form 4 rules).

Context
Restricted-share awards are a form of compensation or long-term incentive and differ from outright open-market purchases or sales; they do not necessarily indicate immediate bullish or bearish trading intent. As a 10% owner, Dr. Rosenwald’s receipt of plan awards reflects insider compensation/ownership adjustments rather than a market trade.